These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34325713)

  • 1. Discordance between apolipoprotein B or non-HDL-cholesterol and LDL-cholesterol in middle-aged and elderly Chinese patients predicts arterial stiffness.
    Qu G; Zhang Z; Zhu H
    Lipids Health Dis; 2021 Jul; 20(1):80. PubMed ID: 34325713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance of Apolipoprotein B, Non-HDL-Cholesterol, and LDL-Cholesterol Predicts Risk of Increased Arterial Stiffness and Elevated Carotid Intima-Media Thickness in Middle-Aged and Elderly Chinese Adults.
    Jia X; Qi Y; Zheng R; Lin L; Hu C; Zhu Y; Cao Q; Wu X; Qi H; Wei R; Zhang Y; Xu M; Xu Y; Wang T; Zhao Z; Chen Y; Li M; Wang W; Bi Y; Lu J
    Front Cardiovasc Med; 2022; 9():906396. PubMed ID: 35665267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification: The CARDIA Study.
    Wilkins JT; Li RC; Sniderman A; Chan C; Lloyd-Jones DM
    J Am Coll Cardiol; 2016 Jan; 67(2):193-201. PubMed ID: 26791067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population.
    Wen J; Huang Y; Lu Y; Yuan H
    Hypertens Res; 2019 Aug; 42(8):1223-1230. PubMed ID: 30918334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.
    Fonseca L; Paredes S; Ramos H; Oliveira JC; Palma I
    Lipids Health Dis; 2020 Jun; 19(1):127. PubMed ID: 32505210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Cao J; Nomura SO; Steffen BT; Guan W; Remaley AT; Karger AB; Ouyang P; Michos ED; Tsai MY
    J Clin Lipidol; 2020; 14(1):109-121.e5. PubMed ID: 31882375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study.
    Sniderman AD; Islam S; Yusuf S; McQueen MJ
    Atherosclerosis; 2012 Dec; 225(2):444-9. PubMed ID: 23068583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance/discordance between serum apolipoprotein B, low density lipoprotein cholesterol and non-high density lipoprotein cholesterol in NATPOL 2011 participants - An epidemiological perspective.
    Solnica B; Sniderman AD; Wyszomirski A; Rutkowski M; Chlebus K; Bandosz P; Pencina MJ; Zdrojewski T
    Int J Cardiol; 2023 Nov; 390():131150. PubMed ID: 37429441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non-HDL-C Levels.
    Sayed A; Peterson ED; Virani SS; Sniderman AD; Navar AM
    JAMA Cardiol; 2024 Aug; 9(8):741-747. PubMed ID: 38865115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remnant Cholesterol is More Strongly Associated with Arterial Stiffness than Traditional Lipids and Lipid Ratios in the General Chinese Population.
    Li B; Zhou X; Liu Y; Zhang Y; Mu Y
    J Atheroscler Thromb; 2024 May; 31(5):587-602. PubMed ID: 38171806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
    Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R
    Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention.
    Sniderman AD; Dufresne L; Pencina KM; Bilgic S; Thanassoulis G; Pencina MJ
    Eur Heart J; 2024 Jul; 45(27):2410-2418. PubMed ID: 38700053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance between remnant cholesterol and low-density lipoprotein cholesterol predicts arterial stiffness progression.
    Wu S; Su X; Zuo Y; Chen S; Tian X; Xu Q; Zhang Y; Zhang X; Wang P; He Y; Wang A
    Hellenic J Cardiol; 2023; 74():24-31. PubMed ID: 37245643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk.
    Sniderman AD; St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
    Am J Cardiol; 2003 May; 91(10):1173-7. PubMed ID: 12745098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.
    Sniderman AD; Islam S; McQueen M; Pencina M; Furberg CD; Thanassoulis G; Yusuf S
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.
    Johannesen CDL; Mortensen MB; Langsted A; Nordestgaard BG
    J Am Coll Cardiol; 2021 Mar; 77(11):1439-1450. PubMed ID: 33736827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.
    Ballantyne CM; Raichlen JS; Cain VA
    J Am Coll Cardiol; 2008 Aug; 52(8):626-32. PubMed ID: 18702965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of Multi-Ethnic Study of Atherosclerosis participants.
    Steffen BT; Guan W; Remaley AT; Stein JH; Tattersall MC; Kaufman J; Tsai MY
    J Clin Lipidol; 2017; 11(5):1181-1191.e1. PubMed ID: 28826575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance between plasma apolipoprotein B levels and cholesterol indices among patients receiving statins and nonstatin treatment: Post-hoc analyses from the U.K. InPractice study.
    Idris I; Tate H; Ahmad A; McCormack T
    J Clin Lipidol; 2011; 5(4):316-23. PubMed ID: 21784378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.